Daily Cosmetic Research Analysis
Safety and outcomes in cosmetic and dermatologic interventions were advanced by three studies: a prospective cohort quantified the time course and distribution of transient adverse events after cryolipolysis; a toxicology case series linked glyoxylic acid hair-straightening products with acute kidney injury and suggested vitamin-based mitigation; and a methods paper introduced a standardized, quantitative scoring system for mineral sunscreen white cast tied to ZnO concentration. Together, these
Summary
Safety and outcomes in cosmetic and dermatologic interventions were advanced by three studies: a prospective cohort quantified the time course and distribution of transient adverse events after cryolipolysis; a toxicology case series linked glyoxylic acid hair-straightening products with acute kidney injury and suggested vitamin-based mitigation; and a methods paper introduced a standardized, quantitative scoring system for mineral sunscreen white cast tied to ZnO concentration. Together, these findings inform patient counseling, product safety regulation, and inclusive formulation design.
Research Themes
- Cosmetic procedure safety profiling
- Consumer product toxicology and regulatory implications
- Methodological innovation for inclusive dermatologic formulations
Selected Articles
1. "Adverse Events Associated with Cryolipolysis Treatment for Body Contouring: A Prospective Observational Study with Three-month Follow-up".
In a multicenter prospective observational study, transient adverse events after cryolipolysis declined from 71.6% immediately to 1.3% at 3 months. Pain resolved within 1 month, while numbness persisted for about 3 months; no paradoxical adipose hyperplasia or deep vein thrombosis was observed. Adverse event patterns varied by treatment area and timepoint.
Impact: Defines the real-world time course and distribution of post-cryolipolysis adverse events across body areas, enabling evidence-based counseling and expectation setting. The prospective design in a high-volume aesthetic setting strengthens safety assessments.
Clinical Implications: Use these data to counsel patients on expected pain resolution (by 1 month) and numbness duration (~3 months), tailor follow-up by treatment area, and reassure regarding the low short-term risk of PAH and DVT while emphasizing vigilance. Supports informed consent and scheduling around transient downtime.
Key Findings
- Overall adverse event rate decreased from 71.6% immediately post-treatment to 1.3% at 3 months.
- No cases of paradoxical adipose hyperplasia (PAH) or deep vein thrombosis (DVT) were observed.
- Pain resolved within 1 month; numbness persisted for approximately 3 months.
- Adverse event peaks differed by area: submental (immediate), flank (1 week), banana roll (1 month), upper arms (3 months).
Methodological Strengths
- Prospective observational design across multiple aesthetic clinics.
- Granular temporal and anatomical profiling of adverse events up to 3 months.
Limitations
- Monitoring cohort of volunteers may introduce selection bias and limit generalizability.
- Three-month follow-up may miss late events such as PAH presenting beyond this window.
Future Directions: Establish longer-term registries to capture late adverse events (including PAH), incorporate objective sensory testing and imaging, and compare device/parameter-specific risk profiles.
BACKGROUND: Cryolipolysis is a nonsurgical procedure for body contouring, and many clinical studies have recently assessed its efficacy and safety. This study aimed to analyze the incidence and duration of transient adverse events (AEs) that many patients experience after cryolipolysis treatment. METHODS: This was a prospective observational study of outpatients in our aesthetic medical group clinics. The patients were recruited as monitors who provided feedback on the device used for treatment and agreed to cooperate with this investigation after three months. For this study, monitored patients could choose to visit on a day between July and August 2023 at one of our clinics throughout Japan. RESULTS: The overall AE rate decreased from 71.6% immediately after treatment to 1.3% at the three-month follow-up. Paradoxical adipose hyperplasia (PAH) and deep vein thrombosis (DVT) were not observed in this study. The submental area and upper arms required the fewest (13.6 days, n = 54) and the greatest (18.0 days, n = 371) mean number of days, respectively. The pain disappeared within one month, whereas the numbness persisted for approximately three months. The highest AE rates were observed in the submental area (after treatment), the flank (1 week after treatment), the banana roll (one month after treatment) and the upper arms (three months after treatment). CONCLUSIONS: The study was successful in collecting an unparalleled amount of AE details in this Asia-Pacific region report, which will be utilized for a safety assessment of cryolipolysis in cosmetic dermatology.
2. Hair straightening and acute kidney injury: a case series from a medical toxicology service.
A retrospective case series identified acute kidney injury in 12 of 13 women after exposure to glyoxylic acid-based hair straightening, with calcium oxalate crystalluria in 27%. Early thiamine and pyridoxine therapy may mitigate toxicity; no patients required dialysis and there were no deaths.
Impact: Reveals an underrecognized cosmetic product-related nephrotoxicity with plausible oxalate-mediated mechanism and suggests a readily available mitigation strategy. This could influence clinical history-taking, acute management, and regulatory oversight of hair-straightening products.
Clinical Implications: In patients presenting with unexplained AKI, specifically inquire about recent hair-straightening treatments and consider early thiamine/pyridoxine alongside fluid resuscitation. Advise avoidance of glyoxylic acid hair products after an event and report cases to health authorities.
Key Findings
- 12/13 patients developed acute kidney injury after exposure to glyoxylic acid hair-straightening products.
- Calcium oxalate crystals were detected in urine in 27% of cases.
- Early thiamine/pyridoxine therapy was associated with absence of AKI in one early-treated patient.
- No patients required hemodialysis and no deaths occurred.
Methodological Strengths
- Systematic case aggregation with consistent clinical and laboratory patterns.
- Toxicological examination of implicated products to identify glyoxylic acid.
Limitations
- Retrospective, small sample, and single-center design limit causal inference.
- Lack of control group and exposure quantification (dose-response) data.
Future Directions: Prospective surveillance with exposure quantification, mechanistic studies on glyoxylic acid metabolism to oxalate, and regulatory risk assessments to guide product reformulation or warnings.
BACKGROUND: Formaldehyde-free, glyoxylic acid-containing hair-straightening treatments have gained popularity, but their safety is unproven. Since 2019, our medical toxicology service has identified multiple cases of acute kidney injury following exposure to these products. This study explores the association between glyoxylic acid-based hair-straightening treatments and nephrotoxicity. METHODS: A retrospective study was conducted between April 2021 and March 2025 at Sourasky Medical Center, Tel Aviv, Israel. Thirteen female patients with symptoms such as nausea, vomiting, and abdominal pain that developed following exposure to glyoxylic acid-containing hair-straightening products were evaluated. Data on demographics, clinical presentation, laboratory results, and management were collected, including toxicological investigation of product ingredients. RESULTS: The mean age of patients was 22 years. Twelve of 13 patients developed acute kidney injury. Urinalysis revealed calcium oxalate crystals in 27% of patients. All patients received intravenous fluids, and eight (61.5%) were treated with thiamine and pyridoxine; the patient who received early treatment did not develop kidney injury. None of the patients required hemodialysis, and there were no deaths. A common feature among the implicated products was the presence of glyoxylic acid, which was potentially linked to the formation of calcium oxalate crystals and subsequent kidney damage. DISCUSSION: These findings highlight a potentially underrecognized risk of kidney toxicity associated with glyoxylic acid-containing hair products. The consistent clinical presentation, presence of urine calcium oxalate crystals, and temporal association with product use suggest a causal relationship. Prompt recognition and early treatment, particularly with thiamine and pyridoxine, may reduce the severity of kidney damage. Further studies and regulatory action are needed to better define the risk and prevent future cases. CONCLUSIONS: This case series suggests an association between glyoxylic acid hair-straightening products and acute kidney injury, and a potential role for thiamine and pyridoxine in mitigating toxicity. Early intervention may reduce the extent of kidney damage.
3. A standardized scoring method for measuring white cast of mineral sunscreens and improving user compliance across diverse skin tones.
This methods study introduced a standardized scoring protocol combining subjective rankings and objective CIELab colorimetry to quantify mineral sunscreen white cast. Increasing ZnO concentration strongly correlated with higher L values and unacceptable white cast, with agreement between in vivo and in vitro assessments.**
Impact: Provides a reproducible, quantitative framework to minimize white cast and improve sunscreen adherence across skin tones, addressing a key barrier to UV protection equity.
Clinical Implications: Dermatology practitioners and formulators can apply this scoring system to select or design mineral sunscreens with acceptable cosmetic elegance, potentially improving adherence and skin cancer prevention in patients sensitive to chemical filters.
Key Findings
- Developed a standardized white-cast scoring protocol combining inter-rater subjective rankings with CIELab* measurements.
- Higher ZnO percentages were strongly correlated with higher L* values (r ≥ 0.822; p < 0.001) and more visible white cast.
- In vivo and in vitro assessments produced substantially consistent white-cast scores; high ZnO concentrations yielded unacceptable white cast.
Methodological Strengths
- Integration of subjective perception with objective colorimetry enhances validity and reproducibility.
- Concordance between in vivo and in vitro methods supports practical formulation screening.
Limitations
- Small sample size (13 volunteers) may limit generalizability across diverse skin tones.
- Tested ZnO formulations may not capture the full range of real-world product matrices and pigments.
Future Directions: Validate the scoring system in larger, diverse cohorts and across real-world product formulations; establish thresholds for acceptable white cast by skin tone categories; link scores to adherence and UV protection outcomes.
INTRODUCTION: Using broad-spectrum sunscreen is an effective practice for preventing skin cancers caused by ultraviolet (UV) radiation. Mineral sunscreens containing zinc oxide (ZnO) and titanium dioxide (TiO2) as physical UV filters are suitable for individuals with sensitive skin or allergies to chemical UV filters. Consumer compliance with sunscreen application depends largely on its cosmetic elegance, especially regarding white cast. Despite this, there is no official method to quantify white cast and help design sunscreens for diverse skin tones. METHODS: To address this gap, we developed white cast scoring protocols that combine 1) inter-rater reliability (ICC) of expert graders and thirteen study volunteers ranking the white cast produced by ZnO test formulations with 2) objective CIELab* measurements determined after sunscreen application both in vivo and in vitro. RESULTS: Our findings demonstrate a significant correlation between increasing ZnO percentages and higher L* values (whiteness) resulting in a more visible white cast, as assessed by Pearson coefficient in vivo (r ≥ 0.822; p < 0.001) and Kruskal-Wallis (p < 0.0001) with Dunn's post hoc pairwise comparisons. White cast scores for the ZnO formulations were substantially consistent across both in vivo and in vitro methodologies, with higher ZnO concentrations producing unacceptable levels of white cast. CONCLUSION: This study provides a white cast scoring system, based on subjective white cast perception and L* values, as a quantitative tool for evaluating and refining mineral sunscreen formulations, contributing to developing more cosmetically elegant sunscreens suitable for a wide range of skin tones.